How dangerous are India’s generic drugs? Very


India relies on the weak oversight of developing countries that make up the bulk of its exports – that’s how it can continue to push substandard and often deadly medicines there. — Bloomberg

FOR a nation that seeks to claim the mantle of “pharmacy to the world,” India is scandalously short on regulatory oversight.

In the last six months, its generic cough syrups have killed dozens of children, its eye drops have caused blindness and its chemotherapy drugs have been contaminated.

Save 30% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 9.73/month

Billed as RM 9.73 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.63/month

Billed as RM 103.60 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
India , genericdrugs , regulation , oversight , scandals

Next In Business News

Foreign funds log second straight week of net inflows of RM716.1mil
Ringgit opens higher against greenback on better-than-expected 4Q GDP estimates
FBM KLCI slips on profit-taking as US-EU geopolitical tension escalates
Trading ideas: Binastra, Capital A, Allianz, MN, Vestland, Genting Plantations, YTL Cement, Pimpinan Ehsan, TH Plantations, Marine & General, FGV, SumiSaujana
Energy transition to propel Sarawak’s future
New tech leaves other sectors behind
Construction companies poised to�sustain growth
If I were an ageing oil palm tree
Hurdles in DBS’ Alliance Bank bid
Germany proposes giving EV buyers subsidies to boost demand

Others Also Read